key: cord-1011805-8wl5w0o0 authors: Lane, Morgan A.; Brownsword, Erik A.; Morgan, Jill S.; Babiker, Ahmed; Vanairsdale, Sharon A.; Lyon, G. Marshall; Mehta, Aneesh K.; Ingersoll, Jess M.; Lindsley, William G.; Kraft, Colleen S. title: Bioaerosol Sampling of a Ventilated Patient with COVID-19 date: 2020-08-04 journal: Am J Infect Control DOI: 10.1016/j.ajic.2020.07.033 sha: 677e1f0354a26603ac6ad0b9fdfd3c533795881b doc_id: 1011805 cord_uid: 8wl5w0o0 Bioaerosol samples were collected in an airborne infection isolation room, bathroom and anteroom of a ventilated patient with coronavirus disease 2019. Twenty-eight samples were negative for SARS-CoV-2 nucleic acid, possibly due to the patient being on a closed-circuit ventilator or the efficiency of the air exchanges in the room. Bioaerosol samples were collected in an airborne infection isolation room, bathroom and anteroom of a ventilated patient with coronavirus disease 2019. Twenty-eight samples were negative for SARS-CoV-2 nucleic acid, possibly due to the patient being on a closed-circuit ventilator or the efficiency of the air exchanges in the room. SARS-CoV-2 is believed to spread primarily through droplets or direct contact, with hospital-acquired transmission increasingly becoming a problem [2] . Recent studies have shown that contact with contaminated surfaces is another possible method of transmission, with contamination of toilets and sinks being a priority in cleaning [3, 4] . However, regular hospital cleaning procedures appear to kill the virus, and viable virus in fecal samples is rarely identified [3, 5] . The virus may also be spread through aerosol-generating procedures, and it is possible that re-aerosolization of virus when healthcare workers remove personal protective equipment (PPE) increases exposure to the virus [6] . With the number of cases and hospitalizations increasing, in order to protect healthcare personnel and uninfected patients in healthcare settings, it is important to understand the characteristics of aerosols containing SARS-CoV-2. While studies conducted during the pandemic have found aerosols containing virus within the healthcare setting, none have explicitly examined aerosols within the room of a patient on a ventilator [3, 6] . While ventilators are assumed to be closed systems, in practice, they can be disconnected during clinical care or while moving the patient for positioning or procedures [7, 8] . We sought to determine if aerosolized SARS-CoV-2 RNA could be found during the care of a ventilated patient who was being placed prone due to profound respiratory failure. Ten NIOSH BC 251 two-stage cyclone samplers were used [9] . The NIOSH samplers separated particles into three size fractions, which are collected in a 15 mL centrifuge tube (>4 µm fraction), a 1.5 mL centrifuge tube (1-4 µm fraction) and on a filter cassette containing a 37mm diameter, polytetrafluoroethylene filter with 2 µm pores (<1 µm fraction). Each sampler was connected with a 6.35-mm Tygon tubing to an air sampling pump (PCXR-4, SKC, Eighty Four, PA) at a 3.5 L/ min flow rate. Two samplers were placed approximately 102 cm and 152 cm above the floor on each of five tripods. Three tripods were placed inside the patient room, one in the bathroom within the patient room, and one in the anteroom (Figure 1 ). The patient room samplers were placed next to the ventilator system (<2 ft away), in the corner along the same wall as the ventilator system, and by the anteroom door (<3 ft from the door). The anteroom sampler was placed <2 ft from the door to the patient room and the sampler in the bathroom was placed by the far wall (<2 ft from the toilet, <6 ft from the door). In an abundance of caution and to simplify disinfection, the sampler tripods were draped in plastic with holes cut out for the air intake and secured with tape. The pump cases were draped with a disposable underpad and secured to the tripods with tape. Following a 6-hour sampling period, collected samples from each sampler were processed as follows: 1) 1000 µl viral transport medium was added to the 15 ml tube, the tube was vortexed, inverted and vortexed, then frozen at -80 °C, 2) 400 µl viral transport medium was added to the 1.5 ml tube, the tube was vortexed, inverted and vortexed and frozen at -80 °C, 3) sterile forceps were used to remove the filter from its cassette and place it in a 15 ml tube, 1000 µl of viral transport medium was added to wet the entire filter, and the tube was vortexed and performed at 25°C for 2 min followed by 50°C for 15 min, followed by an initial denaturation at 95°C for 2 min, followed by 45 cycles of amplification at 95°C for 3s and 55.0°C for 30s. A previously characterized SARS-CoV-2 sample was tested concurrently as a positive control. Fluorescence growth curves which cross the threshold line within 40 cycles (< 40 Ct) were considered positive. Sampling took place in an ICU-level airborne infection isolation room (AIIR) in the Serious Communicable Diseases Unit at Emory University Hospital. The AIIR has negative air pressure relative to the anteroom (0.016 -0.018 in of w.c.) with twenty air exchanges per hour, laminar flow across the patient bed, and HEPA filtration. The adjoining anteroom has negative air pressure relative to the hallway. The patient was confirmed PCR positive for COVID-19 the day before sampling took In total, 30 samples were collected, three from each sampler: one 15 mL centrifuge tube, one 1.5 mL centrifuge tube, and an additional 15 mL centrifuge tube containing the removed 37mm filter. Two samples were unable to be used for testing: a 15 mL tube from the "Ventilator" tripod and a filter from the "Corner" tripod which fell on the floor. Of the 28 tested samples, 4 were positive for RP primer, indicating presence of human nucleic acid material. These included two samples from the patient room "Corner" 102 cm-high sampler, one sample from the room "Door"102 cm-high sampler and one sample from the "Bathroom" 152-high cm sampler ( Table 1) . None of the 28 samples tested were positive for SARS-CoV-2 nucleic acid. In order to protect healthcare personnel with appropriate PPE, there has been considerable discussion on what constitutes an aerosol-generating procedure. Our preliminary study shows that SARS-CoV-2 aerosols were not detected in an AIIR with a COVID-19 postive paitent mechanically-ventilated on a closed-suction device. This was particularly important because this patient was substantially manipulated through pronation and supination in the bed by many healthcare personnel during the 6 hours of sampling. His respiratory status was so poor that these aggressive measures were attempted to keep the patient able to be oxygenated. The healthcare workers were wearing powered air purifying respirators (PAPRs) as well as disposable gowns, two sets of gloves, and booties, in accordance with hospital policy. All PPE except for the PAPR were doffed in the patient room, with the PAPR being doffed in the anteroom. Some studies have detected low amounts of SARS-CoV-2 RNA in aerosol samples collected in healthcare settings where patients were breathing and coughing into the environment while others have not [3, 6, 12, 13] . Our study was performed in an AIIR with laminar flow and a high air exchange rate with the patient on a ventilator with a HEPA filter. These early findings, based upon a single sampling event, suggest that the amount of airborne SARS-CoV-2 was very low. However, it is important to note the limitations of our study. First, we cannot comment on the possibility of virus transmission in this setting, because this study only measured aerosols in the air and did not examine other potential pathways for virus transmission. Further, the sampling may have been too dilute and the amount of RNA may have been below the limit of detection of 10 viral copies/ml. Second, aerosol sampling was conducted for only one patient during one 6-hour sampling period. Third, previous studies have shown that the filtration efficiency of ventilator exhaust filters varies widely, and thus these results cannot be assumed to apply to all ventilators and exhaust filters [14] . Finally, although the patient was positive for COVID-19 in the upper respiratory tract and was diagnosed with acute respiratory distress syndrome, and therefore likely positive in the lower respiratory tract based on recent evidence [13] , we cannot confirm that the patient was actively shedding virus on the day of sampling. Given we cannot understand the full extent of possible environmental contamination in the patient room with aerosol samples alone, surface sampling studies will be conducted along with any aerosol sampling in the future. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient COVID-19) -Transmission COVID-19) Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak. Microbiology Environmental contamination during tracheal suction.: A comparison of disposable conventional catheters with a multiple-use closed system device Cross infection in an intensive care unit by Klebsiella pneumoniae from ventilator condensate Measurement of airborne influenza virus in a hospital emergency department Estimates of the severity of coronavirus disease 2019: a model-based analysis Real-Time RT-PCR Panel for Detection 2019-Novel Coronavirus. 2020: 12. Available at Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center Detection of Air and Surface Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Hospital Rooms of Infected Patients Preventing the transmission of pathogenic microbes during anesthesia This work was supported in part by the Center for AIDS Research (P30 AI050409). The findings and conclusions in this report are those of the authors and do not necessarily